MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00210-025-04884-4

Медицинская библиотека · Naunyn-Schmiedeberg's archives of pharmacology · 2026

Innovative immunotherapy approaches: harnessing synergy of dual checkpoint blockade in oncology.

Shaik Rahaman, Varikuppala Mounika, Badampudi Sathvika, Jabeen Asra, Hamzah Mohammed Anas, Zehra Fatima Uz, Unnisa Adeeb, Mohammed Jaffer Sadik, Azeeza Shaik

СтатьяОбзорПеревод пока не подготовлен

Аннотация

This review offers a comprehensive assessment of synergistic immune checkpoint inhibitor (ICI) strategies and their evolving combinations for cancer immunotherapy, highlighting dual and strategically designed treatment options. It emphasizes essential insights into checkpoint blockade, the tumor microenvironment (TME), and innovative inhibitory and stimulatory targets, including CTLA-4, PD-1/PD-L1, LAG-3, TIM-3, and TIGIT. It discusses preclinical and clinical data demonstrating how combination therapies, such as chemotherapy, radiation, targeted medications, and adoptive cell transfer, can enhance therapeutic responses and circumvent drug resistance. The review systematically outlines important clinical research and regulatory approvals, highlighting improved results in melanoma, non-small cell lung cancer, renal cell carcinoma, and colorectal cancer. A comprehensive assessment of biomarker development, sequencing and timing optimization, and the management of immune-related adverse events is undertaken, in conjunction with novel methodologies such as AI-driven biomarker identification and the impact of the gut microbiome on the efficacy of immune checkpoint inhibitors. The research indicates that the optimal approach to enhance treatment efficacy and precision in cancer immunotherapy is through the implementation of rational combination strategies that address multiple immune evasion mechanisms and incorporate manipulation of the tumor microenvironment. This will improve long-term survival and clinical outcomes across all cancer types.

Для цитирования: Shaik Rahaman, Varikuppala Mounika, Badampudi Sathvika, Jabeen Asra, Hamzah Mohammed Anas, Zehra Fatima Uz, Unnisa Adeeb, Mohammed Jaffer Sadik, Azeeza Shaik. Innovative immunotherapy approaches: harnessing synergy of dual checkpoint blockade in oncology.. Naunyn-Schmiedeberg's archives of pharmacology. 2026. DOI: 10.1007/s00210-025-04884-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.